Companies › ATHE

Alterity Therapeutics Ltd (ATHE)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001131343 · EDGAR filings · Updated 2026-07-28

Alterity Therapeutics Ltd (ATHE) has 15 institutional managers reporting positions valued at $1.12M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-28 — Foreign issuer report (6-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — Foreign issuer report (6-K) filed
• 2026-07-21 — Foreign issuer report (6-K) filed
• 2026-07-09 — Foreign issuer report (6-K) filed
• 2026-07-09 — Foreign issuer report (6-K) filed
• 2026-07-07 — Foreign issuer report (6-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Alterity Therapeutics Ltd has 15 institutional holders.

Data flags from SEC filings

Related companies

PULSENMORE LTD (PLSM) · Lexaria Bioscience Corp (LEXX) · IGC PHARMA INC (IGC) · VSee Health Inc (VSEE) · Mannatech Inc (MTEX) · CHARMING MEDICAL LTD (MCTA)